Get started
Author

Chadi Saba

Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors
2014 · J.-C. Soria, F. DeBraud, et al. · Annals of Oncology · 174
Validation of prognostic scores for survival in cancer patients beyond first-line therapy
2011 · Olivier Trédan, Isabelle Ray-Coquard, et al. · BMC Cancer · 46
PDF
FINESSE: An open, three-cohort, phase II trial testing oral administration of lucitanib in patients with FGFR1-amplified or nonamplified estrogen receptor-positive metastatic breast cancer.
2014 · Fabrice Andre, Fergus Daly, et al. · Journal of Clinical Oncology · 5
Prolonged Anti-Tumor Activity of Lucitanib in Advanced Thyroid Cancer
2014 · J. Capdevila, R. Dienstmann, et al. · Annals of Oncology · 2
PDF
[Neoadjuvant chemotherapy and ovarian cancer].
2006 · Isabelle Ray-Coquard, Chadi Saba, et al. · PubMed · 2
An open-label, Phase 2 study of dapolsertib (MEN1703, SEL24) as monotherapy and in combination with glofitamab in patients with relapsed or refractory aggressive B-cell non-Hodgkin lymphoma
2025 · Herve Ghesquieres, Malgorzata Krawczyk-Kulis, et al. · Blood · 1
PDF
River-52: A Multicenter, Open-Label Clinical Trial of RVU120 in Patients with Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
2024 · Cristina Papayannidis, Krzysztof Mądry, et al. · Blood · 1
PDF
Abstract OT1-1-03: Phase Ib dose allocation study of oral administration of lucitanib given in combination with fulvestrant in patients with estrogen receptor-positive and FGFR1-amplified or non-amplified metastatic breast cancer (INES)
2015 · Mario Campone, Thomas Bachelot, et al. · Cancer Research · 1
340 Preclinical activity of the VEGFR, FGFR and PDGFR inhibitor lucitanib in FGFR2 aberrant endometrial and gastric cancer models
2014 · F. Guffanti, R. Chila, et al. · European Journal of Cancer · 1
Traitements anti-VEGF : un emploi universel ?
2007 · Isabelle Ray‐Coquard, Thomas Bachelot, et al. · Bulletin du Cancer · 1
[Are antiangiogenic antibodies universal for solid tumor?].
2007 · Isabelle Ray-Coquard, Thomas Bachelot, et al. · PubMed · 1
Surveillance du cancer de l’ovaire
2006 · C. Saba · Springer eBooks · 1
LLIVE: A non-interventional multicenter study of first-line Avastin® (bevacizumab) in combination with chemotherapy in patients with metastatic colorectal cancer in Lebanon
2017 · Ali Shamseddine, Sarah Abdel Massih, et al. · Annals of Oncology
Anticorps anti-VEGF: un emploi universel?
2006 · I. Ray-Coquard, T. Bachelot, et al. · ONCOLOGIE
L’hormonothérapie adjuvante chez la femme avant la ménopause
2006 · J.-P. Guastalla, C. Confavreux, et al. · ONCOLOGIE
Traitement multidisciplinaire des tumeurs stromales gastro-intestinales : cas cliniques en situation adjuvante, néoadjuvante, avancée, en échappement
2006 · Isabelle Ray‐Coquard, Chadi Saba, et al. · Bulletin du Cancer
Works count: 16
Citation count: 236
H-index: 3
I10-index: 2
Year
Topic
Type